DualityBio's Next-Generation HER3 ADC DB-1310 Granted FDA Fast Track Designation ...Middle East

SHANGHAI, July 21, 2025 /PRNewswire/ -- DualityBio (HKEX Stock Code: 9606.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to its next-generation HER3-targeting antibody-drug conjugate (ADC) DB-1310. This designation is for the...

Hence then, the article about dualitybio s next generation her3 adc db 1310 granted fda fast track designation was published today ( Tuesday 22/07/2025 - 05:34 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( DualityBio's Next-Generation HER3 ADC DB-1310 Granted FDA Fast Track Designation )

Also on site :

• 30–35 terrorists on radar: Army steps up counterterror ops in J&K; intense vigil amid 'Chillai Kalan'
• No. 20 Virginia notches first 11-win season by beating 25th-ranked Missouri in the Gator Bowl
• Nine Years After Carrie Fisher Died, Billie Lourd Says Mom “Lives on Through Joy” With Kids, Dad Bryan Lourd